Found: 16
Select item for more details and to access through your institution.
Systematic evaluation of levodopa-carbidopa intestinal gel patient-responder characteristics.
- Published in:
- NPJ Parkinson's Disease, 2018, v. 4, n. 1, p. N.PAG, doi. 10.1038/s41531-017-0040-2
- By:
- Publication type:
- Article
DUOGLOBE: One‐Year Outcomes in a Real‐World Study of Levodopa Carbidopa Intestinal Gel for Parkinson's Disease.
- Published in:
- Movement Disorders Clinical Practice, 2021, v. 8, n. 7, p. 1061, doi. 10.1002/mdc3.13239
- By:
- Publication type:
- Article
O1‐02‐06: ABBV‐8E12, A HUMANIZED ANTI‐TAU MONOCLONAL ANTIBODY FOR THE TREATMENT OF EARLY ALZHEIMER'S DISEASE: STUDY DESIGN AND BASELINE CHARACTERISTICS FOR A 96‐WEEK, MULTIPLE DOSE, RANDOMIZED, DOUBLE‐BLIND, PLACEBO‐CONTROLLED PHASE 2 STUDY
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2018, v. 14, p. P218, doi. 10.1016/j.jalz.2018.06.2341
- By:
- Publication type:
- Article
Effects of Levodopa-Carbidopa Intestinal Gel Compared with Optimized Medical Treatment on Nonmotor Symptoms in Advanced Parkinson's Disease: INSIGHTS Study.
- Published in:
- Parkinson's Disease (20420080), 2022, p. 1, doi. 10.1155/2022/1216975
- By:
- Publication type:
- Article
ABT-126 monotherapy in mild-to-moderate Alzheimer's dementia: randomized doubleblind, placebo and active controlled adaptive trial and open-label extension.
- Published in:
- Alzheimer's Research & Therapy, 2016, v. 8, p. 1, doi. 10.1186/s13195-016-0210-1
- By:
- Publication type:
- Article
Safety of Levodopa-Carbidopa Intestinal Gel Treatment in Patients with Advanced Parkinson's Disease Receiving ≥2000 mg Daily Dose of Levodopa.
- Published in:
- Parkinson's Disease (20420080), 2020, p. 1, doi. 10.1155/2020/9716317
- By:
- Publication type:
- Article
Predictors of Response for "Off" Time Improvement With Levodopa-Carbidopa Intestinal Gel Treatment: An Analysis of the GLORIA Registry.
- Published in:
- Frontiers in Neurology, 2020, p. 1, doi. 10.3389/fneur.2020.00419
- By:
- Publication type:
- Article
Safety and efficacy of levodopa-carbidopa intestinal gel: results from an open-label extension study in Japanese, Korean and Taiwanese patients with advanced Parkinson's disease.
- Published in:
- Therapeutic Advances in Neurological Disorders, 2018, v. 11, p. 1, doi. 10.1177/1756286418759315
- By:
- Publication type:
- Article
Correction: Continuous Subcutaneous Foslevodopa/Foscarbidopa in Parkinson's Disease: Safety and Efficacy Results From a 12-Month, Single-Arm, Open-Label, Phase 3 Study.
- Published in:
- 2023
- By:
- Publication type:
- Correction Notice
Continuous Subcutaneous Foslevodopa/Foscarbidopa in Parkinson's Disease: Safety and Efficacy Results From a 12-Month, Single-Arm, Open-Label, Phase 3 Study.
- Published in:
- Neurology & Therapy, 2023, v. 12, n. 6, p. 1937, doi. 10.1007/s40120-023-00533-1
- By:
- Publication type:
- Article
Long-term safety and efficacy of levodopa-carbidopa intestinal gel in advanced Parkinson's disease.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Integrated safety of levodopa-carbidopa intestinal gel from prospective clinical trials.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Levodopa-carbidopa intestinal gel in advanced Parkinson's disease: Final 12-month, open-label results.
- Published in:
- Movement Disorders, 2015, v. 30, n. 4, p. 500, doi. 10.1002/mds.26123
- By:
- Publication type:
- Article
Divalproex Sodium Extended-Release for the Prophylaxis of Migraine Headache in Adolescents: Results of a Stand-Alone, Long-Term Open-Label Safety Study.
- Published in:
- Headache: The Journal of Head & Face Pain, 2009, v. 49, n. 1, p. 45, doi. 10.1111/j.1526-4610.2008.01279.x
- By:
- Publication type:
- Article
Safety and Tolerability of Divalproex Sodium Extended-Release in the Prophylaxis of Migraine Headaches: Results of an Open-Label Extension Trial in Adolescents.
- Published in:
- Headache: The Journal of Head & Face Pain, 2009, v. 49, n. 1, p. 36, doi. 10.1111/j.1526-4610.2008.01299.x
- By:
- Publication type:
- Article
Divalproex Extended-Release in Adolescent Migraine Prophylaxis: Results of a Randomized, Double-Blind, Placebo-Controlled Study.
- Published in:
- Headache: The Journal of Head & Face Pain, 2008, v. 48, n. 7, p. 1012, doi. 10.1111/j.1526-4610.2008.01081.x
- By:
- Publication type:
- Article